Unlock new market opportunities with Remik Pharma’s specialised in-licensing solutions. By strategically acquiring valuable pharmaceutical assets from external partners, we enable you to enhance your product portfolio and extend your market reach. With our deep expertise and customised approach, we ensure the smooth integration of high-quality products and innovative solutions. As a trusted leader in in-licensing, Remik Pharma excels at identifying and acquiring promising pharmaceutical assets, leveraging external expertise and resources to drive effective development and commercialisation.

1. Scouting and Due Diligence: Remik Pharma does all the heavy lifting to identify product candidates available for in-licensing. Our team is adept at conducting thorough due diligence to evaluate each opportunity’s scientific, clinical, regulatory, and commercial potential.
2. Development Planning: Once the licensing rights are secured, Remik Pharma develops a comprehensive development plan for the product. This plan includes outlining the regulatory pathway, conducting additional clinical studies if needed, and optimising manufacturing processes—all of which work towards providing optimum results.
3. Regulatory Affairs: Our highly qualified team ensures that all development activities comply with regulatory requirements in target markets. We manage interactions and document work demanded by statutory agencies for product approval.
4. Commercialisation Strategy: As the product advances through development, Remik formulates a commercialisation strategy. This includes building internal sales and marketing capabilities or partnering with established pharmaceutical companies for commercialisation and distribution.